LA
IDXX icon

Lee Ainslie’s Idexx Laboratories IDXX Stock Holding History

Lee Ainslie’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,481
Closed -$822K – 473
2023
Q4 		$822K Buy
+1,481
New +$695K 0.02% 144
2023
Q3 		– Sell
-809
Closed -$406K – 406
2023
Q2 		$406K Buy
+809
New +$388K 0.01% 283
2022
Q4 		– Sell
-1,492
Closed -$486K – 413
2022
Q3 		$486K Buy
+1,492
New +$548K 0.01% 176
2021
Q3 		– Sell
-1,691
Closed -$1.07M – 710
2021
Q2 		$1.07M Buy
1,691
+1,654
+4,470% +$913K 0.01% 280
2021
Q1 		$18K Sell
37
-75
-67% -$37.6K ﹤0.01% 674
2020
Q4 		$56K Sell
112
-2,484
-96% -$1.11M ﹤0.01% 614
2020
Q3 		$1.02M Sell
2,596
-1,426
-35% -$527K 0.02% 284
2020
Q2 		$1.33M Sell
4,022
-5,993
-60% -$1.74M 0.03% 251
2020
Q1 		$2.43M Buy
10,015
+1,327
+15% +$346K 0.05% 154
2019
Q4 		$2.27M Buy
+8,688
New +$2.29M 0.03% 244
2017
Q4 		– Sell
-32,420
Closed -$5.04M – 190
2017
Q3 		$5.04M Buy
32,420
+8,840
+37% +$1.4M 0.06% 73
2017
Q2 		$3.81M Buy
+23,580
New +$3.83M 0.05% 80

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lee Ainslie's IDXX Position: Q1 2024 in Review

Lee Ainslie sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 1,481 shares — an estimated $822K sold.

Lee Ainslie first reported a position in IDXX in Q2 2017 and held it in 12 quarters. The position peaked at $5.04M in Q3 2017. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • Lee Ainslie reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • Lee Ainslie sold 1,481 Idexx Laboratories shares in Q1 2024, an estimated $822K.
  • Lee Ainslie first reported a position in Idexx Laboratories in Q2 2017 and held it in 12 quarters.
  • Lee Ainslie's Idexx Laboratories position peaked at $5.04M in Q3 2017.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Maverick Capital's 13F filing for Q1 2024, filed 15 May 2024.